1. Home
  2. TRDA vs RELL Comparison

TRDA vs RELL Comparison

Compare TRDA & RELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRDA

Entrada Therapeutics Inc.

BUY

Current Price

$4.60

Market Cap

275.3M

Sector

Health Care

ML Signal

BUY

Logo Richardson Electronics Ltd.

RELL

Richardson Electronics Ltd.

HOLD

Current Price

$18.87

Market Cap

248.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRDA
RELL
Founded
2016
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electronic Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
275.3M
248.1M
IPO Year
2021
2004

Fundamental Metrics

Financial Performance
Metric
TRDA
RELL
Price
$4.60
$18.87
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$19.00
★ $25.50
AVG Volume (30 Days)
★ 327.2K
296.8K
Earning Date
11-05-2026
10-07-2026
Dividend Yield
N/A
★ 1.31%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
$25,421,000.00
★ $228,564,000.00
Revenue This Year
N/A
$12.68
Revenue Next Year
$87.90
$9.21
P/E Ratio
★ N/A
$230.96
Revenue Growth
N/A
★ 9.41
52 Week Low
$4.11
$9.37
52 Week High
$16.45
$23.15

Technical Indicators

Market Signals
Indicator
TRDA
RELL
Relative Strength Index (RSI) 34.84 51.24
Support Level N/A $15.83
Resistance Level $7.89 $19.40
Average True Range (ATR) 0.44 1.14
MACD -0.09 -0.05
Stochastic Oscillator 28.53 38.78

Price Performance

Historical Comparison
TRDA
RELL

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

About RELL Richardson Electronics Ltd.

Richardson Electronics Ltd is a world-wide manufacturer of engineered solutions, green energy products, power grid and microwave tubes, and related consumables; power conversion and RF and microwave components including green energy solutions; tubes for diagnostic imaging equipment; and customized display solutions. It serve customers in alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. Its products and services include design-in support, systems integration, prototype design and manufacturing, testing, logistics, etc. Its segments are Power and Microwave Technologies (PMT), Green Energy Solutions (GES), and Canvys. Majority of Sales is from PMT. Majority of sales is from North America.

Share on Social Networks: